All In MedTech

FDA Clearance Tracker · P140018-S008

VenaSeal Closure System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 30, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 30, 2018

Approved

Time to decision

179 days

Received Aug 4, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P140018-S008
Device name
VenaSeal Closure System
Applicant location
Plymouth, MN
Received
Aug 4, 2017
Decided
Jan 30, 2018
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P140018

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code PJQ

FDA's approval statement

As written in FDA's record.

Approval for modifications to the Instructions for Use and patient brochure.

Source documents

Other decisions for Medtronic Vascular, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.